All News

A bipartisan group of governors from 5 states testified to a Senate committee on ways to stabilize the individual health insurance market and bring down premiums for their residents.

Data presented during PAINWeek show that the rate of drug misuse among teenagers has dropped dramatically.

Bristol-Myers Squibb announced that the FDA has placed a clinical hold on 3 combination trials evaluating its programmed death-1 inhibitor nivolumab (Opdivo) in patients with relapsed/refractory multiple myeloma.

The addition of evolocumab to the standard background therapy for patients with atherosclerotic cardiovascular disease (ASCVD) would exceed the typically accepted range of cost-effectiveness, according to a new study.

The study uncovered differences by race and education level in lifetime obesity status.

After presenting research on the use of a patient-reported distress survey to guide the timing of palliative care discussions, lead author Stuart Goldberg, MD, chief scientific officer for Cota, Inc, discussed how it represents a shift in the paradigm of end-of-life conversations.

A single blood draw that combines the detection of DNA and protein markers could be more sensitive to the earlier detection of pancreatic cancer, according to a new study published in Proceedings of the National Academy of Sciences.

According to USC Department of Nursing Professor Benita Jean Walton-Moss, PhD, alcohol abuse is often underdiagnosed and undertreated in older women because it is often mistaken for other conditions related to aging. Her research emphasizes the importance of identifying social determinants that may increase patients' risk of alcohol misuse, and outlines a thoughtful approach when screening female patients as a medical professional or caregiver.

New research suggests that the expansion of Medicaid under the Affordable Care Act was linked to gains in coverage among children who were already eligible, indicating a "welcome mat" effect.

Overuse of antibiotics not only leads to resistance, but may reduce variety of microbes in the gut and affect the immune system’s ability to fight off disease. Research into the role of the gut’s microbiome in infection found that antibiotic use made neutrophils less effective at fighting infections, and may lead to potential treatments or vaccinations.

Racial bias happens everywhere; it happens, often implicitly, as decisions are made about access to childbirth care in rural America.

Penn Medicine researchers led the analysis of genome sequence information that revealed 16 previously unreported areas connected to type 2 diabetes and 1 connected to coronary heart disease, with 8 variants tied to both conditions.

A new study finds that obstetric units are closing at a concerning rate in rural American counties, highlighting the need to ensure access to obstetric care for vulnerable women.

Cellectis, a clinical-stage biotechnology company, was asked by the FDA to place a clinical hold on 2 phase 1 trials evaluating its allogeneic chimeric antigen receptor-T (CAR-T) cell treatments following the report of a fatality in the first patient treated in one of the studies.

Most emergency department (ED) visits may not be as preventable as once thought. A new study in the International Journal for Quality in Health Care pointed out that while some estimates of "avoidable" ED visits have run anywhere between 4.8% and 90%, the reality is even lower.

The FDA has approved the first 2D digital mammography system that lets patients adjust the level of compression applied to their breast during the imaging procedure.

Quality measurement is here to stay, but a JAMA viewpoint asks if anyone is keeping tabs on the costs of measurement.

According to a study published in The BMJ, while e-cigarettes can assist smokers to quit, the number of days of e-cigarette use will determine quit attempt and quit success.

The assumption in the United States is that once someone with cancer is cured, done with treatment, and healthy, that they are now okay. However, the reality is that survivors contend with lingering challenges that aren’t visible and make it difficult for them to ask for help or admit they need it.

A new draft report from the Institute for Clinical and Economic Review (ICER) indicates that cognitive and mind-body therapies may be valuable additions to usual care for chronic back and neck pain, but that more evidence is needed to understand the cost-effectiveness implications for both conditions.

Psoriasis severity has been linked to increased risk of death in a new study published in the Journal of Investigative Dermatology. Researchers found that the risk of death increased for patients who had more surface area covered by psoriasis.

Despite trials showing that antitumor necrosis factor (TNF) therapy is safe and effective to treat inflammatory diseases such as inflammatory bowel disease and rheumatoid arthritis, but adherence rates remain low.

The rapid-acting insulin received tentative approval based on its similarity to Eli Lilly's Humalog.

The treatment, which was approved nearly 2 decades ago but withdrawn due to safety and efficacy concerns, now has a new indication.

A look at some of the major developments in the chimeric antigen receptor T (CAR-T) cell space.

Desmond Bell, DPM, CWS, said the patients he's seeing in his wound clinic are getting younger, suggesting that the challenge of preventing complications from peripheral artery disease will increase.